EKJFX
Price
$14.25
Change
-$0.04 (-0.28%)
Updated
Sep 20 closing price
GFACX
Price
$66.58
Change
-$0.13 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

EKJFX vs GFACX

Header iconEKJFX vs GFACX Comparison
Open Charts EKJFX vs GFACXBanner chart's image
Allspring Premier Large Co Gr R6
Price$14.25
Change-$0.04 (-0.28%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$66.58
Change-$0.13 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
EKJFX vs GFACX Comparison Chart
Loading...
VS
EKJFX vs. GFACX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKJFX is a StrongBuy and GFACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 290B vs. EKJFX (1.44B). EKJFX (0.00) and GFACX (0.00) have matching dividends . EKJFX was incepted earlier than GFACX: EKJFX (12 years) vs GFACX (24 years). EKJFX is a more actively managed with annual turnover of: 76.00 vs. GFACX (31.00). EKJFX has a lower initial minimum investment than GFACX: EKJFX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 21.68 vs. EKJFX (16.10). GFACX return over 5 years is better than : 42.36 vs. EKJFX (-5.92).
EKJFXGFACXEKJFX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years24 years-
Gain YTD26.60618.673142%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.44B290B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year16.1021.6874%
Returns for 3 years-35.53-7.22492%
Returns for 5 years-5.9242.36-14%
Returns for 10 years-9.0447.07-19%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATUS2.320.10
+4.50%
Altice USA
CARE17.750.15
+0.85%
Carter Bankshares
IGT21.910.09
+0.41%
International Game Technology PLC
IT506.49-0.86
-0.17%
Gartner
QNCX0.74-0.02
-2.65%
Quince Therapeutics